A Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder.

Trial Profile

A Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 08 Mar 2017

At a glance

  • Drugs Aripiprazole; Escitalopram
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2012 Planned number of patients changed from 1200 to 1500 as reported by European Clinical Trials Database.
    • 13 Mar 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
    • 15 Jul 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top